Citi Starts Supernus Pharmaceuticals (SUPN) at Neutral
Tweet Send to a FriendGet Alerts SUPN Hot Sheet
Price: $6.86 +3.16%
Rating Summary:
4 Buy, 1 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 13
Rating Summary:
4 Buy, 1 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 13
Trade SUPN Now!
Citi initiates coverage on Supernus Pharmaceuticals (NASDAQ: SUPN) with a Neutral. PT $6.00.
For an analyst ratings summary and ratings history on Supernus Pharmaceuticals click here. For more ratings news on Supernus Pharmaceuticals click here.
Shares of Supernus Pharmaceuticals closed at $5.94 yesterday, with a 52 week range of $5.16-$7.01.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
For an analyst ratings summary and ratings history on Supernus Pharmaceuticals click here. For more ratings news on Supernus Pharmaceuticals click here.
Shares of Supernus Pharmaceuticals closed at $5.94 yesterday, with a 52 week range of $5.16-$7.01.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Deutsche Bank Starts Kodiak Oil & Gas (KOG) at Hold
- Wedbush Downgrades salesforce.com (CRM) to Neutral
- Topeka Capital Starts InvenSense (INVN) at Buy
Create E-mail Alert Related Categories
New CoverageRelated Entities
Citi
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
